Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Gynecologic Oncology
|
February 16, 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer
Lubna Qamar, Erin Deitsch, Aaron N Patrick, et al.
Nature Communications
|
September 19, 2018
Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
Lingdi Zhang, Hengbo Zhou, Xueni Li, et al.
The Journal of Clinical Investigation
|
September 4, 2009
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L McCoy, Ritsuko Iwanaga, Paul Jedlicka, et al.
Journal of Biomolecular Screening
|
July 24, 2012
Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity
Aaron B Krueger, Seameen J Dehdashti, Noel Southall, et al.
The Journal of Biological Chemistry
|
May 25, 2024
Biochemical characterization of the Eya and PP2A-B55α interaction
Christopher Alderman, Ryan Anderson, Lingdi Zhang, et al.
The Journal of Clinical Investigation
|
April 3, 2012
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
Chu-An Wang, Paul Jedlicka, Aaron N Patrick, et al.
Cancer Research
|
October 29, 2014
Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression
Chu-An Wang, David Drasin, Catherine Pham, et al.
Cell
|
August 14, 2003
A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer
Justin Lamb, Sridhar Ramaswamy, Heide L Ford, et al.
Molecular Cancer Research : MCR
|
January 22, 2017
A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance
Lina Y Dimberg, Christina G Towers, Kian Behbakht, et al.
Breast Cancer Research : BCR
|
July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Ritsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Gynecologic Oncology
|
February 16, 2012
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer
Lubna Qamar, Erin Deitsch, Aaron N Patrick, et al.
Nature Communications
|
September 19, 2018
Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
Lingdi Zhang, Hengbo Zhou, Xueni Li, et al.
The Journal of Clinical Investigation
|
September 4, 2009
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition
Erica L McCoy, Ritsuko Iwanaga, Paul Jedlicka, et al.
Journal of Biomolecular Screening
|
July 24, 2012
Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity
Aaron B Krueger, Seameen J Dehdashti, Noel Southall, et al.
The Journal of Biological Chemistry
|
May 25, 2024
Biochemical characterization of the Eya and PP2A-B55α interaction
Christopher Alderman, Ryan Anderson, Lingdi Zhang, et al.
The Journal of Clinical Investigation
|
April 3, 2012
SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
Chu-An Wang, Paul Jedlicka, Aaron N Patrick, et al.
Cancer Research
|
October 29, 2014
Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression
Chu-An Wang, David Drasin, Catherine Pham, et al.
Cell
|
August 14, 2003
A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer
Justin Lamb, Sridhar Ramaswamy, Heide L Ford, et al.
Molecular Cancer Research : MCR
|
January 22, 2017
A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance
Lina Y Dimberg, Christina G Towers, Kian Behbakht, et al.
Breast Cancer Research : BCR
|
July 7, 2012
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Ritsuko Iwanaga, Chu-An Wang, Douglas S Micalizzi, et al.
Page
of 9